Venture Catalysts, a prominent incubator and accelerator platform, has spearheaded the seed funding round for Aikenist, a company revolutionizing radiology and medical imaging with advanced AI-based workflow solutions. The funding round also saw participation from leading investors, including MARL Fund, Quant Fund, Nandak Growth Catalysts, and notable angel investors, offering Aikenist a strong foundation of expertise and resources for its growth journey.
Miloni Ghatalia, Senior Associate at Venture Catalysts, played a crucial role in facilitating the investment, which marks a significant step forward for Aikenist. The fresh capital will be directed toward enhancing the AI capabilities of its flagship platform, QuickSuite, while also expanding market reach and advancing research and development efforts. The press release noted that this funding will accelerate Aikenist’s mission to redefine medical imaging and radiology.
Apoorva Ranjan Sharma, Co-Founder and Managing Director of Venture Catalysts, stated, “Aikenist is pioneering the future of medical imaging. Their cutting-edge use of AI to improve healthcare aligns with the global push for more efficient and accessible healthcare systems. We believe Aikenist has the potential to transform the $186 billion radiology market in India and the U.S. This investment reaffirms our commitment to supporting groundbreaking innovations that have the power to reshape industries and improve lives.”
Founded by Ashwin Amarapur, Aikenist is on a mission to make medical imaging more accessible, especially for treating critical conditions like cancer, stroke, and neurological disorders. With a flexible SaaS business model, the company offers both subscription and pay-per-use options, making its technology adaptable to healthcare providers of all sizes, from small clinics to large hospital networks.
Aikenist’s flagship platform, QuickSuite, is an AI-powered solution designed to streamline radiology workflows, from scan acquisition to analysis and reporting. It features QuickRad, QuickScan—a patented MRI scanning technology—and QuickDiag, a suite of tools for detecting and quantifying diseases. With over 300 installations in India and internationally, Aikenist is processing about 40 million images per month and continues to grow rapidly.
Ashwin Amarapur, the company’s founder, highlighted the impact of their technology: “We are focused on delivering faster, affordable, and efficient medical imaging. Our patented solution cuts MRI scan times by 70% and reduces radiology reporting times by 80%, enabling faster patient interventions, particularly in critical conditions like stroke and trauma. We are democratizing access to medical imaging, making it more affordable and accessible to people worldwide. We appreciate the strong backing from our investors in helping us achieve this mission.”
This funding round positions Aikenist to advance its cutting-edge technology further and continue its mission to transform medical imaging and healthcare accessibility.